EIF2AK4 mutations in pulmonary capillary hemangiomatosis

Area of Science:

• Genetics
• Molecular Biology
• Vascular Biology

Background:

• Pulmonary capillary hemangiomatosis (PCH) is a rare, high-mortality vascular disorder characterized by capillary proliferation of unknown etiology.
• Familial clustering suggests a potential genetic basis for PCH, yet the causative genes remain unidentified.

Observation:

• Exome sequencing identified compound mutations in eukaryotic translation initiation factor 2 α kinase 4 (EIF2AK4) in brothers with PCH.
• Screening of unrelated PCH patients revealed additional EIF2AK4 mutations in both familial and sporadic cases.
• EIF2AK4, a kinase regulating angiogenesis, is implicated in PCH pathogenesis.

Findings:

• Compound mutations in EIF2AK4 are associated with familial and sporadic PCH.
• Heterozygous carriers were identified in an affected family, suggesting autosomal recessive inheritance.
• EIF2AK4 mutations are a likely cause of autosomal-recessive PCH.

Implications:

• This discovery identifies EIF2AK4 as a key gene in PCH, paving the way for genetic diagnostics.
• Understanding the role of EIF2AK4 in angiogenesis may lead to targeted therapies for PCH.
• Genetic insights into PCH can improve patient counseling and family planning.